SUPPRESSION OF CELLULAR P53 PROMOTES CYTOTOXICITY OF ONCOLYTIC VECTOR AT THE MODELS OF HUMAN GLIOBLASTOMA
https://doi.org/10.17650/1726-9784-2015-14-1-25-28
Abstract
Glioblastoma multiforme resistance requires a new approach for glioma therapy. Protein p53 is one of the main cellular oncogene, overexpressed in 50% of brain tumor cases. Impact of p53 attenuation was evaluated in the presence of oncolytic adenovirus and temodar, which exhibit anti-glioma effect using in vitro glioma models. Using U87 human glioma cells we observed an additive effect between alkilated chemotherapeutic agent temodar and oncolytic adenovirus which results into p53 inhibition. It occurs that attenuation of p53 using PFTa inhibitor, significantly prolongs cell death type II - autophagy and, therefore improves effect mediated by autophagy induced agents. In conclusion, combination of PFTa and temodar might represent a powerful therapeutic combination which sensibilises glioma cells to the infection with oncolytic vector.
About the Authors
I. V. Ulasov
The Center for Advanced Brain Tumor Treatment, Swedish Medial Center, Seattle, USA; FSBSI «NN. Blokhin Russian Cancer Research Center»
Russian Federation
Russian Federation
N. V. Kaverina
FSBSI «NN. Blokhin Russian Cancer Research Center»
Russian Federation
Russian Federation
A. Yu. Baryshnikov
FSBSI «NN. Blokhin Russian Cancer Research Center»
Russian Federation
Russian Federation
References
1. Уласов И.В., Каверина Н.В., Кадагидзе З.Г., Барышников А.Ю. Антиглиомная аденовирусная виротерапия: механизм, регуляция и клинические перспективы // Российский биотерапевтический журнал. - 2014. - Т. 13, № 2. - С. 11-8.
2. Уласов И.В., Тусон А., Барышников А.Ю. Белок фибера аденовируса человека обеспечивает стабильность вирусных капсидов // Российский биотерапевтический журнал. - 2014. - Т. 13, № 2. - С. 51-5.
3. Badie B., Goh C.S., Klaver J., Herweijer H., Boothman D.A. Combined radiation and p53 gene therapy of malignant glioma cells //Cancer Gene Ther. - 1999. - 6. - P. 155-62.
4. Bao S., Wu Q., McLendon R.E. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response // Nature. - 2006. - 444. - P. 756-60.
5. el-Deiry W.S., Tokino T., Velculescu V.E. et al. WAF1 a potential mediator of p53 tumor suppression // Cell. - 1993. - 75. - P. 817-25.
6. Galvin-Burgess K.E., Travis E.D., Pierson K.E., Vivian J.L. TGF-beta-superfamily signaling regulates embryonic stem cell heterogeneity: selfrenewal as a dynamic and regulated equilibrium // Stem Cells. - 2013. - 31. - P. 48-58.
7. Kremenetskaya O.S., Logacheva N.P., Baryshnikov A.Yu. et al. Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells // Oncology Research. - 1997. - 9. - P. 155-66
8. Ulasov I.V., Tyler M.A., Rivera A.A. et al. Evaluation of E1A double mutant oncolytic.. // J Med Virol. - 2008. - 80. - P. 1595-603.
9. Ulasov I.V., Zhu Z.B., Tyler M.A. et al. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma // Hum Gene Ther. - 2007. - 18. - P. 589-602.
10. Ulasov I.V., Sonabend A.M., Nandi S. et al. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo // Br J Cancer. - 2009. - 100. - P. 1154-64.
11. Xu G.W., Mymryk J.S., Cairncross J.G. Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide // Int J Cancer. - 2005. - 116. - P. 187-92.
12. Yamashita K., Nakashima S., You F. et al. Overexpression of immediate early gene X-1 (IEX-1) enhances gamma-radiation-induced apoptosis of human glioma cell line, U87-MG. // Neuropathology. - 2009. - 29. - P. 20-4.
Review
For citations:
Ulasov I.V., Kaverina N.V., Baryshnikov A.Yu. SUPPRESSION OF CELLULAR P53 PROMOTES CYTOTOXICITY OF ONCOLYTIC VECTOR AT THE MODELS OF HUMAN GLIOBLASTOMA. Russian Journal of Biotherapy. 2015;14(1):25-28. (In Russ.) https://doi.org/10.17650/1726-9784-2015-14-1-25-28
Views:
279
Email this article 
